Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Peptides commonly sold for muscle growth include growth hormone secretagogues such as CJC-1295, ipamorelin, sermorelin, tesamorelin, GHRP-2, GHRP-6 and hexarelin, along with IGF-1 LR3, mechano growth factor, follistatin, and recovery-marketed compounds like BPC-157 and TB-500. While some of these do raise growth hormone or IGF-1 levels in the body, human evidence that they meaningfully increase muscle size or strength in healthy adults is weak, and most are sold as unapproved "research only" products with no guarantee of purity or dosing accuracy. Reported risks include water retention, joint pain, numbness, elevated blood sugar and insulin resistance, and unclear long-term effects, and nearly all are banned in tested sport. There are several important factors to weigh before using them, including drug interactions, underlying health conditions, and symptoms that may signal harm. See below for the full details you should consider.
If you are noticing symptoms like swelling, tingling, unusual fatigue, rapid weight changes, persistent joint pain, or blood sugar changes while using or considering these products, it is worth getting clarity quickly rather than guessing. A free, instant, online symptom check asks targeted questions about what you are experiencing, helps you understand possible causes, and points you toward the right level of care and the questions to raise with a clinician. It takes only a few minutes, requires no appointment, and can help you separate harmless side effects from warning signs that need prompt attention.
Last reviewed for medical accuracy: 09/26/2026
Interest in muscle building peptides has grown as athletes, bodybuilders and fitness enthusiasts seek alternatives to traditional steroids and supplements. Peptides are short chains of amino acids that can influence hormone release, tissue repair or muscle growth. Below is an evidence-based overview of the most common “muscle building peptides,” how they work, what research shows, and key safety considerations.
Growth Hormone Releasing Peptides (GHRPs)
Growth Hormone Releasing Hormone (GHRH) Analogs
Insulin-Like Growth Factor-1 (IGF-1) Variants
Follistatin-344
Thymosin Beta-4 (TB-500) & BPC-157
Stimulating Growth Hormone (GH):
GHRPs and GHRH analogs prompt the pituitary gland to release GH, which in turn boosts IGF-1 production in the liver and muscle. GH and IGF-1 drive protein synthesis, muscle cell proliferation and fat metabolism.
Inhibiting Myostatin:
Follistatin-344 binds to myostatin and blocks its activity. Since myostatin naturally restrains muscle growth, blocking it can theoretically lead to rapid hypertrophy.
Enhancing Tissue Repair:
TB-500 and BPC-157 upregulate angiogenesis (new blood vessel formation) and collagen production, speeding recovery from micro-tears and supporting overall muscle health.
GHRP-6, GHRP-2 and CJC-1295
Ipamorelin
IGF-1 LR3
Follistatin-344
TB-500 & BPC-157
Overall, most evidence comes from small-scale or animal studies. Robust, placebo-controlled human trials are lacking for many peptides marketed for muscle building.
Before trying any peptide regimen, consider:
If you’re experiencing unexplained symptoms—fatigue, swelling, joint pain or hormonal changes—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Speak to a doctor before starting any peptide, especially if you have:
Discuss potential drug interactions and baseline lab evaluations.
Consider conventional, evidence-based approaches first:
Muscle building peptides can stimulate growth hormone release, inhibit myostatin or speed tissue repair, but most human data are limited. Potential gains may be real but modest, and safety concerns are significant. Always verify the purity of any product, monitor your health closely and discuss risks and benefits with a qualified healthcare professional. If you experience serious or life-threatening symptoms, seek medical attention immediately.
Speak to a doctor about any treatment that could impact your health long term.
(References)
* Tipton KD, Wolfe RR. Exercise, protein metabolism, and muscle growth. Int J Sport Nutr Exerc Metab. 2001 Mar;11(1):109-32. doi: 10.1123/ijsnem.11.1.109. PMID: 11255140.
* Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res. 2010 Oct;24(10):2857-72. doi: 10.1519/JSC.0b013e3181e840f3. PMID: 20847704.
* Sharma M, McFarlane C, Kambadur R, Kukreti H, Bonala S, Srinivasan S. Myostatin: expanding horizons. IUBMB Life. 2015 Aug;67(8):589-600. doi: 10.1002/iub.1392. Epub 2015 Aug 25. PMID: 26305594.
* Farshidfar F, Pinder MA, Myrie SB. Creatine Supplementation and Skeletal Muscle Metabolism for Building Muscle Mass- Review of the Potential Mechanisms of Action. Curr Protein Pept Sci. 2017;18(12):1273-1287. doi: 10.2174/1389203718666170606105108. PMID: 28595527.
* Liu L, Liu X, Bai Y, Tang N, Li J, Zhang Y, Wu J, Wang X, Wei J. Neuregulin-1β modulates myogenesis in septic mouse serum-treated C2C12 myotubes in vitro through PPARγ/NF-κB signaling. Mol Biol Rep. 2018 Dec;45(6):1611-1619. doi: 10.1007/s11033-018-4293-6. Epub 2018 Sep 3. PMID: 30178217.
* Lee EJ, Shaikh S, Baig MH, Park SY, Lim JH, Ahmad SS, Ali S, Ahmad K, Choi I. MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators. Int J Mol Sci. 2022 Apr 11;23(8). doi: 10.3390/ijms23084222. Epub 2022 Apr 11. PMID: 35457038; PMCID: PMC9031736.
* Wu Y, Liu X, Fan Y, Zuo H, Niu X, Zuo B, Xu Z. MiR-34b Regulates Muscle Growth and Development by Targeting SYISL. Cells. 2025 Mar 5;14(5). doi: 10.3390/cells14050379. Epub 2025 Mar 5. PMID: 40072107; PMCID: PMC11898696.
* Männistö A, Tonttila K, Ortega-Alonso A, Nurmi H, Uusitalo-Kylmälä L, Amudhala Hemanthakumar K, Saikkala E, Myllykangas S, Vertainen S, Nissinen TA, Pasternack A, Ritvos O, Alitalo KK, Hulmi JJ, Kivelä R. Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth. Am J Physiol Cell Physiol. 2025 Aug 1;329(2):C540-C559. doi: 10.1152/ajpcell.00966.2024. Epub 2025 Jul 7. PMID: 40622896.
* Zhang M, Liu S, Wang Y, Shan S, Cang M. HO-1 Suppression by Co-Culture-Derived IL-6 Alleviates Ferritinophagy-Dependent Oxidative Stress to Potentiate Myogenic Differentiation. Cells. 2025 Aug 10;14(16). doi: 10.3390/cells14161234. Epub 2025 Aug 10. PMID: 40862713; PMCID: PMC12384154.
* Liu X, Yao Y, Yan J, Zeng M, Fan X, Tang Y, Li J, Liu Y, Yan S, Wang W, Chen L, Chen R, Huang Y, Calnan H, Wang H, Gardner G, Yang Y, Tang Z. RPS27L Enhances Myogenesis and Muscle Mass by Targeting IGF1 Through Liquid-Liquid Phase Separation. Adv Sci (Weinh). 2025 Nov;12(44):e12354. doi: 10.1002/advs.202512354. Epub 2025 Aug 31. PMID: 40886325; PMCID: PMC12667544.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.